You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 10,201,517


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,201,517
Title:Brimonidine gel compositions and methods of use
Abstract: Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline particles after an extended period of storage.
Inventor(s): Buge; Jean-Christophe (Nice, FR), Nadau Fourcade; Karine (Villeneuve Loubet, FR), Meunier; Cyril (St. Raphael, FR)
Assignee: Galderma Laboratories, L.P. (Fort Worth, TX)
Application Number:15/220,501
Patent Claims: 1. A topical gel composition, comprising: 0.05% to 5% (w/w) brimonidine or brimonidine tartrate; 0.1% to 0.20% (w/w) methylparaben; 0.3% to 0.4% (w/w) phenoxyethanol; 0.80% to 1.50% (w/w) carbomer; 9.0% to 13.0% (w/w) total polyol, wherein the topical gel composition has a pH of 4.5 to 7.5, and wherein when the concentration of methylparaben is greater than 0.15% (w/w), the concentration of carbomer is less than 1.25% (w/w).

2. The topical gel composition of claim 1, wherein the total polyol comprises about 4.5% to 6.5% (w/w) a first polyol, and one or more additional polyols.

3. The topical gel composition of claim 1, wherein the carbomer is selected from the group consisting of carbomer 934P, carbomer 974P, and carbomer 980.

4. The topical gel composition of claim 1, comprising: 0.1% to 0.6% (w/w) brimonidine tartrate; 0.1% to 0.15% (w/w) methylparaben; 0.3% to 0.4% (w/w) phenoxyethanol; 0.80% to 1.50% (w/w) carbomer; 4.5% to 6.5% (w/w) propylene glycol; 4.5% to 6.5% (w/w) glycerol; and purified water wherein the pH of the topical gel composition is adjusted to 5.0 to 6.5 by an adequate amount of sodium hydroxide aqueous solution.

5. The topical gel composition of claim 4, comprising greater than 0.3% (w/w) phenoxyethanol.

6. The topical gel composition of claim 5, further comprising 0.04% to 0.08% (w/w) water dispersible form of titanium dioxide.

7. A topical gel composition, comprising: 0.1% to 0.6% (w/w) brimonidine tartrate; 0.1% to 0.15% (w/w) methylparaben; 0.3% to 0.4% (w/w) phenoxyethanol; 0.80% to 1.50% (w/w) carbomer; 4.5% to 6.5% (w/w) propylene glycol; 4.5% to 6.5% (w/w) glycerol; 0.04% to 0.08% (w/w) water dispersible form of titanium dioxide; and purified water wherein the pH of the topical gel composition is 5.0 to 6.5.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.